2. Signaling Pathways
  3. Immunology/Inflammation
  4. Kallikrein
  5. Kallikrein Isoform

Kallikrein

 

Kallikrein Related Products (27):

Cat. No. Product Name Effect Purity
  • HY-122543A
    PPACK II
    		Inhibitor
    PPACK II is an irreversible and specific glandular and plasma kallikreins inhibitor.
  • HY-139787A
    Donidalorsen sodium
    		Inhibitor
    Donidalorsen (sodium) is an antisense oligonucleotide designed to reduce the production of prekallikrein (PKK). PKK plays an important role in the activation of inflammatory mediators associated with acute attacks of Hereditary angioedema (HAE).
  • HY-143476
    Plasma kallikrein-IN-2
    		Inhibitor
    Plasma kallikrein-IN-2 (Compound 198) is a potent plasma kallikrein (PKal) inhibitor with an IC50 of 0.1 nM. Plasma kallikrein-IN-2 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research.
  • HY-150052
    Plasma kallikrein-IN-3
    		Inhibitor
    Plasma kallikrein-IN-3 is a plasma kallikrein inhibitor (IC50: 0.15 μM). Plasma kallikrein-IN-3 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research.
  • HY-19101
    ONO-3307
    		Inhibitor
    ONO-3307 is a protease inhibitor that competitively inhibits a variety of proteases including trypsin, thrombin, plasma kallikrein, plasmin, pancreatic kallikrein, and chymotrypsin. ONO-3307 alleviates endotoxin-induced experimental disseminated intravascular coagulation (DIC) in rats. ONO-3307 can be used in the study of thrombosis and protease-mediated diseases.
  • HY-163464
    Plasma kallikrein-IN-5
    		Inhibitor
    Plasma kallikrein-IN-5 (Compound 20) is a potent covalent inhibitor of plasma potassium kinin peptide (Pka) with IC50 values of 66 nM and 70 pM at 1 minute and 24 hours, respectively. Plasma kallikrein-IN-5 can be used IN the study of hereditary angioedema (HAE).
  • HY-P0237
    KKI-5
    KKI-5 is a specific inhibitor of tissue kallikrein. KKI-5 can attenuate breast cancer cell invasion.